All Articles

Longevity

AI-Powered Low-Dose CT Screening Cuts Lung Cancer Mortality 20% in NLST Trial

Cureus review analyzes AI-powered low-dose CT screening that reduced lung cancer deaths 20% in NLST trial. Biohackers integrate it into healthspan protocols.

Biohacking

Stanford RCT Achieves AI Clinician Parity as BTC Holds $74K

Longevity

Cureus Review: AI-Powered Low-Dose CT Lung Screening Hits 95% Sensitivity

Longevity

Sarasota Memorial's AI Early Lung Cancer Detection Spots 11 Cases in 3,000 CT Scans

Longevity

All Articles

AI-Powered Low-Dose CT Screening Cuts Lung Cancer Mortality 20% in NLST Trial

Stanford RCT Achieves AI Clinician Parity as BTC Holds $74K

Cureus Review: AI-Powered Low-Dose CT Lung Screening Hits 95% Sensitivity

Sarasota Memorial's AI Early Lung Cancer Detection Spots 11 Cases in 3,000 CT Scans

AI-Powered Low-Dose Lung Scans Hit 95% Sensitivity

Vibrant’s AI Essentials Launches: BTC Hits $74K

AI Lung Cancer Detection Boosts Survival 92% at Sarasota

AI Low-Dose CT Lung Cancer Screening Cuts Mortality 20% in NLST Trial

UMaine NIH AI Medicine Event Sparks Longevity Boom, BTC +3.6%

AWS Agentic AI Launches Amazon Bio Discovery: BTC Surges 5.2% to $75,569

Cureus 67-Study Review: AI Language Models Hit 92% Precision in Oncology

AI Language Models in Oncology: Cureus Reviews 42 Studies